Opioids in rheumatic diseases.
Opioids are the most potent analgesics available and are well established for the treatment of severe acute, surgical, and cancer pain. However, their use to ameliorate chronic noncancer pain (CNCP) is still controversial because of the side effects, such as tolerance, somnolence, confusion, constipation, addiction, withdrawal, and anxiety about disapproval by regulatory bodies. Chronic rheumatic diseases along with low-back pain and arthritis are among the leading causes of CNCP. This article will focus on the role of opioids in chronic rheumatic diseases. Furthermore, the peripheral effects of opioids on pain and inflammation in rheumatic diseases will be outlined.
Lang
L J
LJ
Klinik für Anästhesiologie und operative Intensivmedizin, Charité Campus Benjamin Franklin, Freie Universität Berlin, Berlin, Germany. leonie.lang@charite.de
Pierer
M
M
Stein
C
C
Baerwald
C
C
D000701:Analgesics, Opioid / Q000009:adverse effects* / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000628:therapy*; D002908:Chronic Disease / Q000188:drug therapy; D006801:Humans; D007249:Inflammation / Q000188:drug therapy; D017116:Low Back Pain / Q000188:drug therapy; D010003:Osteoarthritis / Q000628:therapy*; D010146:Pain / Q000188:drug therapy
D000701:Analgesics, Opioid